Status:
COMPLETED
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Venous Thromboembolism
Deep Vein Thrombosis
Eligibility:
All Genders
20-84 years
Phase:
PHASE2
Brief Summary
The objective of this study is to assess the efficacy, safety and dose-response relationship of DU-176b compared with placebo for the prevention of venous thromboembolism in patients after elective to...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral total knee arthroplasty
Exclusion
- risks of hemorrhage
- thromboembolic risks
- weight less than 40 kg
- pregnant, suspect pregnancy, or subjects who want to become pregnant
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
523 Patients enrolled
Trial Details
Trial ID
NCT01203072
Start Date
July 1 2006
End Date
July 1 2008
Last Update
February 25 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan